2,670 件 ・ 関連度順
概要と使いどころ
[omh] Pull request or changes to vet: bug-first review with evidence. Use when the user says: code-review, review, audit, find bugs, release gate, claim audit, evidence audit, README claim.
日本語の概要は準備中です。原文の説明を表示しています。
[omh] Choosing between coding agents on evidence: compare executor or agent choices on reproducible tasks using quality, cost, time, tool, and evidence metrics. Use when the user says: agent-evaluation, agent evaluation, agent eval, agent benchmark, executor evaluation, executor benchmark, compare agents, compare codex claude.
日本語の概要は準備中です。原文の説明を表示しています。
Validate screenshot and viewer HTML quality for PR evidence. Run this after adding or modifying images under .agents/evidence/pr/ or .agents/recordings/, or after generating a new viewer HTML file. Combines image quality checks (resolution, blankness, file size) with Playwright-based viewer rendering verification.
日本語の概要は準備中です。原文の説明を表示しています。
Use when the user asks to "build my brand-safety exclusion lists", "set placement / topic / content exclusions before launch", "add network and audience exclusions", or "prep the A1 brand-safety evidence for the auditor"; produces a placement/network exclusion list, a content-suitability & sensitive-topic block list, an audience/negative-audience exclusion set, and a packaged A1 brand/placement-safety evidence file for the gate. Not for building the audiences you target — use audience-segment-builder; not for computing the RQS or issuing the A1 verdict — use ad-account-auditor. 品牌安全/排除位置/否定受众列表
日本語の概要は準備中です。原文の説明を表示しています。
Execute automate SOC 2 audit preparation including evidence gathering, control assessment, and compliance gap identification. Use when you need to prepare for SOC 2 audits, assess Trust Service Criteria compliance, document security controls, or generate readiness reports. Trigger with phrases like "SOC 2 audit preparation", "SOC 2 readiness assessment", "collect SOC 2 evidence", or "Trust Service Criteria compliance".
日本語の概要は準備中です。原文の説明を表示しています。
Produce a redacted AssemblyAI diagnostic bundle for support and incident triage. Use when evidence is needed without exposing keys, URLs, audio, transcripts, or prompts. Trigger with "AssemblyAI debug bundle" or "support evidence".
日本語の概要は準備中です。原文の説明を表示しています。
Assemble a minimal redacted Attio diagnostic bundle with request fingerprints, schema context, retry evidence, and environment metadata. Use when escalating an Attio integration failure without leaking CRM data or secrets. Trigger with "Attio debug bundle", "Attio support evidence", or "collect Attio diagnostics".
日本語の概要は準備中です。原文の説明を表示しています。
Collect a bounded, secret-safe Algolia diagnostic bundle for an incident or support escalation. Use when a reproducible search or indexing failure needs portable evidence. Trigger with "Algolia debug bundle", "collect Algolia diagnostics", or "Algolia support evidence".
日本語の概要は準備中です。原文の説明を表示しています。
Prepare evidence-bounded, constructive peer-review drafts and structured manuscript assessments. Use for authorized review of scientific manuscripts, protocols, preprints, or research proposals; reporting-guideline selection; claim–evidence checks; methods, statistics, reproducibility, ethics, figure/table, and citation critique; or revision-response planning.
日本語の概要は準備中です。原文の説明を表示しています。
Build evidence-traceable market research reports and assumption-driven market sizing or forecast scenarios. Use for market definition, industry and customer evidence, competitive landscapes, TAM/SAM/SOM reconciliation, forecast sensitivity, and auditable report scaffolds.
日本語の概要は準備中です。原文の説明を表示しています。
Compile current scholarly evidence for a scientific manuscript or research brief. Use when the user explicitly asks to gather literature, references, background evidence, competing findings, or a manuscript research packet. Uses Parallel Search by default, Parallel Extract for source verification, Parallel Research for explicitly deep/exhaustive work, optional explicit Parallel Chat, and optional Perplexity only when requested or allowed as a failure fallback.
日本語の概要は準備中です。原文の説明を表示しています。
FLOW framework integration for bloggers. Evidence-led content workflow using the Find, Optimize, Win loop with stage-specific AI prompts from the FLOW knowledge base (30 blog-applicable prompts, CC BY 4.0). Use when user says "FLOW", "FLOW framework", "blog flow", "evidence-led blogging", "find optimize win", or wants stage-specific blog prompts.
日本語の概要は準備中です。原文の説明を表示しています。
AI citation readiness audit as part of SEO, covering classic Google search and AI search surfaces together. Use whenever the user wants their content to rank or be cited in ChatGPT, Perplexity, Claude, Gemini, Copilot, You.com, Google AI Overviews, or Google AI Mode. AI citation optimization audit scoring blog posts for major answer surfaces. Evaluates evidence-backed citability, purpose clarity, entity clarity, structured data, and AI crawler accessibility. Suggests evidence-backed explanations and a 0-100 AI Citation Readiness score. Use when user says "geo", "ai citation", "ai optimization", "citation audit", "aeo", "perplexity optimization", "chatgpt citation".
日本語の概要は準備中です。原文の説明を表示しています。
Produces executive-level research — market sizing, competitor mapping, trend analysis, and strategic intelligence — grounded in cited sources with the confidence in each claim made explicit. Use this to analyze a market or industry, map competitors, evaluate a market-entry or build-versus-buy decision, produce a research brief, or assemble evidence for a decision. Also use when comparing options that need a structured, evidence-based verdict rather than an opinion.
日本語の概要は準備中です。原文の説明を表示しています。
Orchestrates a systematic review and meta-analysis workflow following PRISMA 2020 guidelines, from protocol development through multi-database search, screening, data extraction, and evidence synthesis. Use when conducting evidence-based reviews, meta-analyses, or scoping revi...
日本語の概要は準備中です。原文の説明を表示しています。
Design evidence-discovery and validation workflows for drug repurposing studies by integrating disease mechanisms, drug-target logic, expression reversal, real-world evidence, and validation routes into a closed-loop study blueprint.
日本語の概要は準備中です。原文の説明を表示しています。
Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.
日本語の概要は準備中です。原文の説明を表示しています。
Converts an audited medical research gap into a complete, structured, gap-traceable study design. Always use this skill whenever a user already has one or more candidate research gaps and wants to transform them into an executable biomedical research plan rather than re-run broad topic ideation. Covers six gap-to-design patterns (evidence-completion, mechanism-resolution, cell-state/context-mapping, translation-bridge, causality-upgrade, population/stage-specific) and always outputs one recommended primary protocol, a gap-to-design dependency map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, and verified design-support literature rules. Never fabricate references. Preserve claim-evidence discipline and do not replace a topic-specific gap with a generic workflow.
日本語の概要は準備中です。原文の説明を表示しています。
Extends a mechanistic or association-level biomedical finding into a staged validation pathway that moves from descriptive evidence toward stronger functional support, mechanistic specificity, and clinical relevance. Use this skill when a user has a pathway, biomarker, cell-state, target, mechanism, or association finding and needs to decide what should be validated next, in what order, and which evidence layers are necessary versus optional. Do not default to maximal validation stacks. Build a structured validation ladder with a primary route, stronger upgrade route, and optional extensions.
日本語の概要は準備中です。原文の説明を表示しています。
Designs a structured real-world evidence study using EHR, claims, or registry data, with explicit handling of time zero, eligibility windows, exposure definitions, outcome windows, censoring, confounding control, and target-trial-emulation logic. Use this skill when the user needs study-type design and protocol framing for an observational clinical study based on routine-care data. Do not invent database fields, follow-up completeness, linkage, coding validity, or causal identifiability.
日本語の概要は準備中です。原文の説明を表示しています。
Generates complete reference-grounded single-drug adverse-effect network-pharmacology research designs from a user-provided drug, adverse event, and desired evidence depth. Always use this skill when a user wants to design, plan, or upgrade a conventional network-pharmacology study centered on one fixed drug and one fixed adverse-effect endpoint, using drug-target prediction, adverse-event target collection, overlap analysis, PPI hub prioritization, enrichment interpretation, molecular docking, and optional orthogonal transcriptomic or literature validation. Covers five study patterns (canonical hub-first, cardiotoxicity or electrophysiology-oriented, immune-inflammatory adverse effect, organ-toxicity pathway context, translational validation) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with a recommended primary plan, dependency/evidence map, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path, verified-reference pack, and self-critical risk review.
日本語の概要は準備中です。原文の説明を表示しています。
Extracts concrete unmet clinical needs from guidelines, reviews, real-world studies, and clinical-practice evidence. Use this skill when a user wants to turn broad medical research value into specific clinical pain points such as weak early detection, poor risk stratification, treatment-response heterogeneity, monitoring gaps, diagnostic delay, undertreatment, overtreatment, or implementation failure. Always ground unmet-need claims in retrieved evidence and distinguish true care gaps from generic statements of importance.
日本語の概要は準備中です。原文の説明を表示しています。
Identifies translationally meaningful paths for bioinformatics findings by mapping omics or computational discoveries to diagnosis, stratification, prognosis, treatment-response, monitoring, or target-nomination use cases, while auditing bridge evidence, assayability, and validation burden. Use this skill when a user wants to know whether a bioinformatics finding can be framed as a stronger translational topic without overclaiming clinical relevance. Always separate statistical signal from translational value, and never imply clinical utility, targetability, or validation depth without explicit evidence support.
日本語の概要は準備中です。原文の説明を表示しています。
Clarifies a vague clinical or biomedical research idea into a structured, bounded, searchable, researchable, and testable question. Always use this skill whenever a user has an early-stage clinical or research thought, an over-broad topic, an ill-defined evidence question, or an unclear problem statement that must be translated into a question framing suitable for literature retrieval, evidence synthesis, gap analysis, study design, or downstream protocol planning. Never jump straight to answering the substantive medical question unless the user explicitly asks for that. Focus first on question framing, boundary setting, and downstream-ready formulation.
日本語の概要は準備中です。原文の説明を表示しています。